Literature DB >> 11703165

Chronic fatigue syndrome: oxidative stress and dietary modifications.

A C Logan1, C Wong.   

Abstract

Chronic fatigue syndrome (CFS) is an illness characterized by persistent and relapsing fatigue, often accompanied by numerous symptoms involving various body systems. The etiology of CFS remains unclear; however, a number of recent studies have shown oxidative stress may be involved in its pathogenesis. The role of oxidative stress in CFS is an important area for current and future research as it suggests the use of antioxidants in the management of CFS. Specifically, the dietary supplements glutathione, N-acetylcysteine, alpha-lipoic acid, oligomeric proanthocyanidins, Ginkgo biloba, and Vaccinium myrtillus (bilberry) may be beneficial. In addition, research on food intolerance is discussed, since food intolerance may be involved in CFS symptom presentation and in oxidation via cytokine induction. Finally, recent evidence suggests celiac disease can present with neurological symptoms in the absence of gastrointestinal symptoms; therefore, celiac disease should be included in the differential diagnosis of CFS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703165

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  37 in total

1.  Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients.

Authors:  Iva V Smirnova; Martin L Pall
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

Review 2.  Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide.

Authors:  Salih Ozgocmen; Huseyin Ozyurt; Sadik Sogut; Omer Akyol
Journal:  Rheumatol Int       Date:  2005-11-20       Impact factor: 2.631

3.  High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome.

Authors:  Thozhukat Sathyapalan; Stephen Beckett; Alan S Rigby; Duane D Mellor; Stephen L Atkin
Journal:  Nutr J       Date:  2010-11-22       Impact factor: 3.271

Review 4.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

5.  Lipid replacement/antioxidant therapy as an adjunct supplement to reduce the adverse effects of cancer therapy and restore mitochondrial function.

Authors:  Garth L Nicolson
Journal:  Pathol Oncol Res       Date:  2005-09-29       Impact factor: 3.201

6.  Hurt, tired and queasy: Specific variants in the ATPase domain of the TRAP1 mitochondrial chaperone are associated with common, chronic "functional" symptomatology including pain, fatigue and gastrointestinal dysmotility.

Authors:  Richard G Boles; Holly A Hornung; Alastair E Moody; Thomas B Ortiz; Stacey A Wong; Julie M Eggington; Christine M Stanley; Mu Gao; Hongyi Zhou; Stephen McLaughlin; Amir S Zare; Katherine M Sheldon; Jeffrey Skolnick; Kevin J McKernan
Journal:  Mitochondrion       Date:  2015-05-27       Impact factor: 4.160

7.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

Review 8.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

9.  Mitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements.

Authors:  Garth L Nicolson
Journal:  Integr Med (Encinitas)       Date:  2014-08

10.  Traditional chinese medicine for chronic fatigue syndrome.

Authors:  Rui Chen; Junji Moriya; Jun-Ichi Yamakawa; Takashi Takahashi; Tsugiyasu Kanda
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.